Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel R Chamberlain

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Plos One|August 16, 2014
Systemic RNAi delivery to the muscles of ROSA26 mice reduces lacZ expressionJessica Wei, Joel R Chamberlain
Nature Medicine|February 6, 2010
Muscling in: Gene therapies for muscular dystrophy target RNAJoel R Chamberlain, Jeffrey S Chamberlain
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2017
Progress toward Gene Therapy for Duchenne Muscular DystrophyJoel R Chamberlain, Jeffrey S Chamberlain
Current Opinion in Genetics & Development|May 5, 2009
Therapy for neuromuscular disordersAndrea L H Arnett, Joel R Chamberlain, Jeffrey S Chamberlain
Human Molecular Genetics|September 19, 2008
Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophinGlen B Banks, Ariana C Combs, Joel R Chamberlain, et al.
Muscle & Nerve|June 1, 2010
On fixing broken muscle...fall seven times, stand up eight--Japanese proverbGregory T Carter, Jay J Han, Joel R Chamberlain, et al.
Molecular Therapy. Nucleic Acids|January 14, 2020
Endogenous MicroRNA Competition as a Mechanism of shRNA-Induced CardiotoxicityMeredith M Course, Kathryn Gudsnuk, Nitin Desai, et al.
Molecular Pharmaceutics|December 6, 2005
Chimeric Ad5 vectors expressing the short fiber of Ad41 show reduced affinity for human intestinal epitheliumFilippos Kesisoglou, Joel R Chamberlain, Phyllissa Schmiedlin-Ren, et al.
Physical Medicine and Rehabilitation Clinics of North America|May 25, 2010
Aging with muscular dystrophy: pathophysiology and clinical managementGregory T Carter, Michael D Weiss, Joel R Chamberlain, et al.
Human Molecular Genetics|June 18, 2015
Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophyDarren R Bisset, Ewa A Stepniak-Konieczna, Maja Zavaljevski, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Plos One|August 16, 2014
Systemic RNAi delivery to the muscles of ROSA26 mice reduces lacZ expressionJessica Wei, Joel R Chamberlain
Nature Medicine|February 6, 2010
Muscling in: Gene therapies for muscular dystrophy target RNAJoel R Chamberlain, Jeffrey S Chamberlain
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2017
Progress toward Gene Therapy for Duchenne Muscular DystrophyJoel R Chamberlain, Jeffrey S Chamberlain
Current Opinion in Genetics & Development|May 5, 2009
Therapy for neuromuscular disordersAndrea L H Arnett, Joel R Chamberlain, Jeffrey S Chamberlain
Human Molecular Genetics|September 19, 2008
Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophinGlen B Banks, Ariana C Combs, Joel R Chamberlain, et al.
Muscle & Nerve|June 1, 2010
On fixing broken muscle...fall seven times, stand up eight--Japanese proverbGregory T Carter, Jay J Han, Joel R Chamberlain, et al.
Molecular Therapy. Nucleic Acids|January 14, 2020
Endogenous MicroRNA Competition as a Mechanism of shRNA-Induced CardiotoxicityMeredith M Course, Kathryn Gudsnuk, Nitin Desai, et al.
Molecular Pharmaceutics|December 6, 2005
Chimeric Ad5 vectors expressing the short fiber of Ad41 show reduced affinity for human intestinal epitheliumFilippos Kesisoglou, Joel R Chamberlain, Phyllissa Schmiedlin-Ren, et al.
Physical Medicine and Rehabilitation Clinics of North America|May 25, 2010
Aging with muscular dystrophy: pathophysiology and clinical managementGregory T Carter, Michael D Weiss, Joel R Chamberlain, et al.
Human Molecular Genetics|June 18, 2015
Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophyDarren R Bisset, Ewa A Stepniak-Konieczna, Maja Zavaljevski, et al.
Pageof 2